Full history for every metric is available with a Kvantra account

Stock profile

AnPac Bio-Medical Science Co., Ltd. (ANPC)

Country: ChinaSector: HealthcareIndustry: BiotechnologyExchange: NASDAQ

Delisted · last close 19 May 2023

Current price
4.37 USD-5.41%
Last close 19 May 2023
Benchmarks

Key financial summary

Financials in CNY
201720182019202020212022TTM
Total revenueCNY m6101121181212
Operating profitCNY m-84-105
Net profitCNY m-39-42-102-81-120-104-101
EPS reportedCNY-54.18-87.27
Operating cashflow per shareCNY-28.80-28.80
Capex per shareCNY0.830.83
FCF per shareCNY-29.63-29.63
Free cash flowCNY m-57-46
Net debtCNY m103
Book value equityCNY m-14-14
Book value per shareCNY-7.15-7.15
Number of sharesm1.911.91
DPS (TTM paid)CNY0.000.00

Financial summary

Financials in CNY
201720182019202020212022TTM
Value
P/E TTMx--
P/B LTMx-4.51-13.22
P/S LTMx5.1215.02
P/FCF LTMx-1.09-3.95
EV/EBITDA LTMx-0.72-2.19
EV/Sales LTMx5.9915.28
Earnings Yield LTM%-167.85%-187.93%
FCF Yield%-91.79%-25.33%
Quality
ROE%757.52%1140.0%
ROIC%-2066.2%-2066.2%
Operating margin%-698.59%-698.59%
Gross margin%69.21%69.21%
FCF/Sales%-470.38%-470.38%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%-33.04%-33.04%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx-4.60-3.72
Net Debt/EBITDAx-0.10-0.10
EBIT/Net interestx-225.57-225.57
Net debt/market cap%16.92%1.74%
Net debt/Equityx-0.76-0.23
Gross debt/equityx-0.90-0.90

Company overview

AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types. These diagnostic tools leverage the company's unique Cancer Differentiation Analysis (CDA) technology and associated devices. AnPac Bio primarily provides these solutions to corporate entities and life insurance companies across the People's Republic of China. Additionally, the company extends its offerings to include comprehensive physical examination package services. AnPac Bio was established in 2010 and maintains its main operational base in Lishui, China.

WebsiteN/A
IndustryBiotechnology
CountryChina
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 19 May 2023

AnPac Bio-Medical Science Co., Ltd. (ANPC)

ANPC · NASDAQ · Healthcare
4.37 USD-5.41%
Benchmarks
Financialsin CNY
20212022TTM
About

AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types. These diagnostic tools leverage the company's unique Cancer Differentiation Analysis (CDA) technology and associated devices. AnPac Bio primarily provides these solutions to corporate entities and life insurance companies across the People's Republic of China. Additionally, the company extends its offerings to include comprehensive physical examination package services. AnPac Bio was established in 2010 and maintains its main operational base in Lishui, China.

IndustryBiotechnology
CountryChina
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free